BioSpace News Archive

Three late breakers, one oral presentation and 27 posters showcase AJOVY as a preventive treatment for migraine

Number of U.S. pediatric dentists projected to increase by over 60 percent within the next decade

Affecting approximately 1 percent of the population, VWD is a common inherited bleeding disorder that occurs when the blood lacks a protein that helps clotting.

Microlearning opportunities, ANCC accreditation advance the vision for lifelong learning

IBH announced today the launch of the industry’s most comprehensive solution to help address the opioid crisis.

Acutus Medical today announced the appointment of Scott Huennekens as Executive Chairman of the Board of Directors.

Cantel Medical Corp. (NYSE: CMD) announced today that Eric Nodiff, Executive Vice President, General Counsel and Secretary, will be retiring on July 31, 2019 after 32 years of service to the Company and Jeff Mann has been appointed as Senior Vice President, General Counsel and Secretary, effective August 1, 2019.

Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5.XE), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, is pleased to report that its partner Zambon S.p.A. and Valeo Pharma Inc. announced today the launch of Onstryv® (safinamide) for the treatment of Parkinson’s disease in Canada.

JDRF, the leading global organization funding type 1 diabetes (T1D) research, today brought leading voices in the T1D community, including more than 160 children with the disease, to Washington to urge Congress to renew the Special Diabetes Program.

Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today announces it has received the approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with a Phase 1 clinical trial of its lead myvacTM candidate TG4050.